Renovaro (RENB) shares rose 8.4% in recent Friday trading after the company said its Renovaro Cube unit has launched a collaboration with artificial intelligence cloud infrastructure company Nebul to back projects for the early detection of cancer and other diseases.
Financial details weren't provided.
The project will use AI technologies and high-performance computing to "transform diagnostic and therapeutic methodologies," Renovaro said.
"The potential for multi-cancer early detection screening and recurrence testing will be powered by AI chips that can process vast data sets," Renovaro Chief Executive David Weinstein said in a statement.
Price: 1.68, Change: +0.13, Percent Change: +8.41
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.